Balance of post.
Moreover, it appears to be looking to scale up production with reputable partners and recently a Omega Diagnostics spokesperson (who is a UK RTC member) confirmed to Sharebuyers that it has held initial early talks with Avacta. With Omega having multiple opportunities of its own with the UK RTC and Mologic – to even consider adding Avacta to the mix suggests there must be a substantial and pressing opportunity.And lastly, the Telegraph noted last week that Moonshot is more developed than currently understood.
Therefore, we think there is some substance to this rumour across multiple fronts
Copied & pasted from somewhere I read today. I am sure it has been menrioned that Deepverge will partner with Avacta on some project or other. Let's hope it's this one.
Avacta boss ‘heavily involved’ in Operation Moonshot say city sources
October 4, 2020ShareBuyers Editorial Team
The rumour mill is swirling that Avacta is ‘heavily involved’ in the government’s Operation Moonshot programme.
Operation Moonshot is focused on delivering 10 million tests a day by next year and rapid COVID-19 tests will be an instrumental part to achieving this. Boris Johnson has also previously outlined a vision where everyone can have a COVID-19 test in the morning, get a result and continue with their day.
Today’s rumour comes from ‘thisismoney’ who note that ‘city sources’ claim that Alastair Smith, CEO of Avacta is ‘heavily involved’ in the mass testing plans as part of its stock watch feature.
The source does not go into further details.
Adding some substance to the rumour; our thoughts
With a gold-standard rapid saliva-based COVID-19 test it is understandable that Avacta has been linked as having a key role in Operation Moonshot.
Likewise, Avacta is taking its time to produce something that is likely industry-leading and sets the benchmark. We also know that the government is firmly focused on antigen testing for the masses – so the case for Avacta is strong.
Moreover, it appears to be looking to scale up production with reputable partners and recently a Omega Diagnostics spokesperson (who is a UK RTC member) confirmed to Sharebuyers that it has held initial early talks with Avacta. With Omega having multiple opportunities of its own with the UK RTC and Mologic – to even consider adding Avact
Debcashew
Looks to me from Friday 10,767,000 shares traded if you look under the heading Skin Share price above. It says over 6.5M bought & just over 3M sold. The other 1+M will probably show up on Monday as delayed trade. Not sure how accurate LSE are though.
Best of luck with your investments.
Ark1.
I also saw this on the 6 o'clock news. I noted the reporter was at Addenbrooke's hospital in Cambridge. There is definitely a link hear somewhere. Dr Muhunthan Thillai is the lead consultant for lung fibrosis at the Royal Papworth hospital which must come under the same hospital trust as Addenbrooke's. He is an NFX non executive director appointed in late 2019. I think he has 6 million share options at a set price (not sure how much but do remember he does have to pay for them). I have also read somewhere that he is one of many people involved in this drug testing programme. Huge insensitive for him personally to push NFX to the fore.
Might just be another reason why Dr Dan is very quiet at present. Roll on June. DYOR.
How many shareholders here think that NFX has the capability to rise to the levels we are currently seeing in NCYT. Once we get positive news flow with ref to NXP002 & NXP004 along with the payments due from China for NXP001, rest of world rights & also Ebers with the cannabinoids I personally see a big re-rate for these shares.
Please DYOR.
Looking at the trades below something has happened & all showing as sells at 13p
2019-10-08 15:05:51 13.00 945,000 19.00 21.00 Sell 122,850 O
2019-10-08 15:04:15 13.00 11,152,523 19.00 21.00 Sell 1,449,828 O
2019-10-08 15:04:00 13.00 1,230,000 19.00 21.00 Sell 159,900 O
2019-10-08 15:02:54 13.00 770,000 19.00 21.00 Sell 100,100 O
2019-10-08 15:02:00 13.00 415,000 19.00 21.00 Sell 53,950 O
2019-10-08 15:01:37 13.00 855,000 19.00 21.00 Sell 111,150 O
2019-10-08 14:57:14 13.00 430,000 19.00 21.00 Sell 55,900
Not sure if it's helpful to anyone but the 1st to 7th October is the golden week Public Holidays in China so the whole country is virtually closed down for the week including the Chinese Stock Market. I would doubt we will get any news re the payment next week unless our chairman comes back with news.
https://whatculture.com/gaming/eas-project-atlas-vs-google-stadia-what-you-need-to-know?page=1
If you have done your research on this company & believe what Dan Gooding says about there not being a problem with the Chinese payment other the bureaucracy caused by the takeover of NSB by Yatai then it really is time to fill your boots at this level. If CPI want to dump there shares I personally will sell the majority of my other investments to hoover up as many as I can afford. As I said yesterday (Quoting the great Warren Buffet) be greedy when others are fearful. Please do not take this as investment advice. This is all IMHO - DYOR. I strongly believe that news will arrive in the not to distant future & providing the payment comes though this share will multi bag.
GLA LTH's
Ark 1
I have topped up 4 times now in the last 2 days. twice in my SIPP & twice in my ISA.
I live or die by my own decisions and I believe this is a great opportunity to gather as many shares as I can afford.
Remember the Warren Buffet saying.
Be greedy when others are fearful & be fearful when others are greedy.
GLTA LTH's.
Ark 1.
When looking at the Buys v Sells, especially when the spread is somewhere between 5 - 10% of the share price.
Many showing as Buys could be sells & visa versa.
It looks on todays trades so far many more buys than sells but this could be the MM's collecting stock for when news does come out.
All IMHO of course.
Ark1